No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
PNFP Pinnacle Financial Partners
- 80.290
- -1.240-1.52%
Close Apr 26 16:00 ET
- 80.290
- 0.0000.00%
Post 16:01 ET
6.20BMarket Cap11.55P/E (TTM)
82.275High80.080Low448.32KVolume81.010Open81.530Pre Close36.28MTurnover0.59%Turnover Ratio11.25P/E (Static)77.20MShares92.10052wk High1.05P/B6.07BFloat Cap42.92252wk Low0.88Dividend TTM75.64MShs Float108.358Historical High1.10%Div YieldTTM2.69%Amplitude1.788Historical Low80.918Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Pinnacle Financial Partners (NASDAQ:PNFP) Is Paying Out A Dividend Of $0.22
Form 144 | Pinnacle Financial Partners(PNFP.US) Director Proposes to Sell 1.13 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 26, $Pinnacle Financial Partners(PNFP.US)$、$Pinnacle Financial Partners Inc(PNFPP.US)$ Director CALLICUTT RICHARD D II intends to sell 13,923 shares of its common stock on
Pinnacle Financial Partners' Governance and Strategy Affirmed at Annual Meeting
Optimism for Pinnacle Financial Partners (NASDAQ:PNFP) Has Grown This Past Week, Despite One-year Decline in Earnings
These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But investors can boost returns by picking market-beating companies to own shares in. For exampl
Form 144 | Pinnacle Financial Partners(PNFP.US) Officer Proposes to Sell 5.83 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 25, $Pinnacle Financial Partners(PNFP.US)$、$Pinnacle Financial Partners Inc(PNFPP.US)$ Officer M. Terry Turner intends to sell 72,000 shares of its common stock on Apr 25,
Form 144 | Pinnacle Financial Partners(PNFP.US) Officer Proposes to Sell 9.34 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 25, $Pinnacle Financial Partners(PNFP.US)$、$Pinnacle Financial Partners Inc(PNFPP.US)$ Officer Robert A. McCabe Jr. intends to sell 115.25K shares of its common stock on Ap
Comments
The insider selling at around the current share price of US$80.90 is a cause for slight concern. The lack of insider purchases in the last year, despite significant insider ownership, does not inspire confidence in the company.
Have Pinnacle Financial Partners Insiders Been Selling Stock?Efficient markets hypothesis implies markets are over-reactive and investors may not always be rational. The firm's higher EPS growth versus its annual share price increment indicates a potential surge in market caution towards the stock.
Insider trading at Pinnacle Financial Partners suggests a bearish signal as there's been more selling than buying in the past year. While strong insider ownership is seen as positive, extensive share selling warrants closer inspection.
ColumnsTop upgrades and downgrades on 7/7: KSS, BG, GTLB, PATH and more
Upgrades
• $Allegiance(ABTX.US$ : Raymond James Upgrades to Outperform from Market Perform - PT $43
• $Bunge(BG.US$: JPMorgan Upgrades to Overweight from Neutral - PT $106 (from $130)
• $Cerence(CRNC.US$ : RBC Capital Upgrades to Sector Perform from Underperform - PT $27 (from $28)
• $First Mid Bancshares(FMBH.US$ : Raymond James Upgrades to Outperform from Market Perform - PT $45
• $Lamar Advertising Co(LAMR.US$ : Citigroup Up...
• $Allegiance(ABTX.US$ : Raymond James Upgrades to Outperform from Market Perform - PT $43
• $Bunge(BG.US$: JPMorgan Upgrades to Overweight from Neutral - PT $106 (from $130)
• $Cerence(CRNC.US$ : RBC Capital Upgrades to Sector Perform from Underperform - PT $27 (from $28)
• $First Mid Bancshares(FMBH.US$ : Raymond James Upgrades to Outperform from Market Perform - PT $45
• $Lamar Advertising Co(LAMR.US$ : Citigroup Up...
11
ColumnsToday's pre-market stock movers: PLUG, CMPI, JNJ, LMT and more
Gainers:
• $Checkmate Pharmaceuticals(CMPI.US$ +331.5% (Regeneron Pharma (REGN) to acquire CMPI for $10.50/share in cash)
• $Axsome Therapeutics(AXSM.US$ +27.9% (received and agreed to Postmarketing Requirements/Commitments proposed by the FDA with respect to the New Drug Application for its AXS-05 product candidate for the treatment of major depressive disorder)
• $Super Micro Computer(SMCI.US$ +14.3% (earnings report)
• $Plug Power(PLUG.US$ +9.24% (t...
• $Checkmate Pharmaceuticals(CMPI.US$ +331.5% (Regeneron Pharma (REGN) to acquire CMPI for $10.50/share in cash)
• $Axsome Therapeutics(AXSM.US$ +27.9% (received and agreed to Postmarketing Requirements/Commitments proposed by the FDA with respect to the New Drug Application for its AXS-05 product candidate for the treatment of major depressive disorder)
• $Super Micro Computer(SMCI.US$ +14.3% (earnings report)
• $Plug Power(PLUG.US$ +9.24% (t...
16
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg